Melisa Cooper - Concepedia

Author

Melisa Cooper

Birmingham City Hospital

Also Known As

M A Cooper, M Cooper, M. A. COOPER, M. A. Cooper, Melisa Cooper

Publications

739

Citations

H-Index

Concepts

All Affiliations

Birmingham City Hospital Guest Hospital

About

Melisa Cooper is an author at Birmingham City Hospital specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	450
2	Health Sciences	2	2	38
3	Microbiology	2	2	38
4	Diabetes	1	1	235
5	Nephrology	1	1	235

Melisa Cooper

Publications

700

Citations

H-Index

Page 1

	Year	Citations
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy Julia A. Breyer, Raymond P. Bain, Joni K. Evans, Kidney International Glomerular DiseaseHemodialysisUrologyRenal DiseaseRenal Function	1996	235
Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin Robert A. Wise, M Logan, Melisa Cooper, Antimicrobial Agents and Chemotherapy Inflammatory Exudate PenetrationInflammatory ExudateMean Percent PenetrationPharmacological StudyMedicine	1991	71
Pharmacokinetics and inflammatory fluid penetration of sparfloxacin James H. Johnson, Melisa Cooper, J. M. Andrews, Antimicrobial Agents and Chemotherapy	1992	69
In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent Melisa Cooper, J. M. Andrews, J. P. Ashby, Journal of Antimicrobial Chemotherapy	1990	62
Meropenem pharmacokinetics and penetration into an inflammatory exudate Robert A. Wise, M Logan, Melisa Cooper, Antimicrobial Agents and Chemotherapy InflammationInflammatory ExudateAnti-inflammatoryCantharidine-induced Inflammatory ExudateMedicine	1990	54
The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin Melisa Cooper, K. Nye, J. M. Andrews, Journal of Antimicrobial Chemotherapy InflammationPharmacological StudyAntibioticsInflammatory Fluid PenetrationPharmacology	1990	52
Experience of Symptoms and Disease Impact in Patients with Adenomyosis Linda Nelsen, William R. Lenderking, Robin Pokrzywinski, Patient	2017	45
Phase 1, placebo-controlled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee Nancy J. Olsen, Valerie Klusas Branch, Geetha Jonnala, BMC Musculoskeletal Disorders	2010	31
In-vitro comparison of the postantibiotic effect of vancomycin and teicoplanin Melisa Cooper, Ye Jin, J. P. Ashby, Journal of Antimicrobial Chemotherapy Greater PaePharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceDrug Resistance	1990	21
Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions Melisa Cooper, J. M. Andrews, R. Wise Journal of Antimicrobial Chemotherapy	1991	19

Page 1